Immunotherapy

Source: Mycosis Fungoides (Including Sézary Syndrome) Treatment (PDQ®)–Patient Version, National Cancer Institute.

Source updated: February 12, 2025 · Captured 2026-09-09.

Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.

NCI-linked patient version: mycosis fungoides and Sezary syndrome subset Patient source covers mycosis fungoides/Sezary syndrome; do not apply to all other cutaneous T-cell lymphomas.

Context: Treatment Option Overview / Seven types of standard treatment are used:

Immunotherapy is a treatment that uses the patient's immune system to fight cancer. Substances made by the body or made in a laboratory are used to boost, direct, or restore the body's natural defenses against cancer. This cancer treatment is a type of biologic therapy.

Source links and citations

Interferon: This treatment interferes with the division of mycosis fungoides and Sézary cells and can slow tumor growth.

Source links and citations

See Drugs Approved for Non-Hodgkin Lymphoma for more information. (Mycosis fungoides and Sézary syndrome are types of non-Hodgkin lymphoma.)

Source links and citations

Drugs Approved for Non-Hodgkin Lymphoma

Preserved source evidence · Independent clinical review pending · Not medical advice